Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

A Multi-Center Clinical Trial of Allogeneic Hematopoietic Stem Cell Transplants in Transfusion Dependent Thalassemia

Blood (2024) 144 (Supplement 1): 378.

https://doi.org/10.1182/blood-2024-204984

Published: 2024

Journal Articles

Rapid, Efficient and Durable Fetal Hemoglobin Production Following CS-101 Treatment in Transfusion-Dependent β-Thalassemia Participants: An Autologous, Ex Vivo Edited CD34+ Stem Cell Product Using the Innovative Transformer Base Editor (tBE)

Yongrong Lai, Rongrong Liu, Lijie Wang, Xu-Kai Ma, Yaliang Li, Gaohui Yang, Lingling Shi, Jia Wei, Zhenbin Wei, Xuemei Zhou, Kewei Lan, Yan Zhang, Xiaodun (Susan) Mou, Li Yang, Jia Chen

Blood (2024) 144 (Supplement 1): 4962.

https://doi.org/10.1182/blood-2024-200691

Published: 2024

Journal Articles

Addition of Daclizumab to Standard Graft-Versus-Host Disease Prophylaxis in Patients with Thalassemia Major Undergoing Transplantation from Alternative Donor Hematopoietic Stem-Cell Transplantation: A Single-Center Retrospective Analysis from China

Blood (2024) 144 (Supplement 1): 2152.

https://doi.org/10.1182/blood-2024-205021

Published: 2024

Journal Articles

Pulmonary Dysfunction in Patients with Transfusion-Dependent Thalassemia

Xiao Liang, Gaohui Yang, Lingling Shi, Lianjin Liu, Zhenbin Wei, Yumei Huang, Jing Bai, Yi Liang, Lingyuan Pan, Zhaoping Gan, Yu Lin, Yibin Yao, Ying Tang, Huicheng Huang, Xuemei Zhou, Qifa Liu, Yongrong Lai, Rongrong Liu

Blood (2024) 144 (Supplement 1): 1096.

https://doi.org/10.1182/blood-2024-204971

Published: 2024

Journal Articles

Using T-Lymphocyte Subsets at Engraftment to Predict the Risk of Acute Graft Versus Host Disease in Patients with Thalassemia Major：Development of a New Predictive Nomogram

Hongwen Xiao, Gaohui Yang, Qiuling Huang, Zhenbin Wei, Zhaoping Gan, Meiqing Wu, Zeyan Shi, Huicheng Huang, Zhaofang Pan, Lianjin Liu, Lingling Shi, Zhongming Zhang, Qifa Liu, Rongrong Liu, Yongrong Lai

Blood (2024) 144 (Supplement 1): 2139.

https://doi.org/10.1182/blood-2024-205258

Published: 2024

Journal Articles

The Optimal Dose of Anti-Thymocyte Globulin in Beta-Thalassemia Major Following Matched Sibling Donor Hematopoietic Stem Cell Transplantation: A Single-Center, Open-Label, Randomized, Controlled Clinical Study

Qiuling Huang, Rongrong Liu, Lianjin Liu, Meiqing Wu, Lingling Shi, Gaohui Yang, Zhongming Zhang, Qifa Liu, Yongrong Lai

Blood (2024) 144 (Supplement 1): 2134.

https://doi.org/10.1182/blood-2024-205204

Published: 2024

Journal Articles

Safety and Efficacy of RM-001 (Autologous HBG1/2 Promoter-modified CD34+ Hematopoietic Stem and Progenitor Cells) in Patients with Transfusion-Dependent β-Thalassemia

Rongrong Liu, Li Wang, Hui Xu, Xiaolin Yin, Junbin Liang, Wenqiang Xie, Gaohui Yang, Yaoyun Li, Yali Zhou, Lei Shi, Bin Xiao, Lingling Shi, Zeyan Shi, Xuemei Zhou, Xiangmin Xu, Jianpei Fang, Yongrong Lai, Junjiu Huang, Xinhua Zhang

Blood (2023) 142 (Supplement 1): 4994.

https://doi.org/10.1182/blood-2023-181453

Published: 2023

Journal Articles

Addition of Daclizumab to Standard Graft-Versus-Host Disease Prophylaxis in Patients with Thalassemia Major Undergoing Transplantation from Related Haploidentical Donor and Unrelated Donor Hematopoietic Stem-Cell Transplantation: A Single-Center Retrospective Analysis from China

Rongrong Liu, Gaohui Yang, Lingling Shi, Lianjin Liu, Zhongming Zhang, Cuifeng Huang, Zhenbin Wei, Beicai Liu, Zhaoping Gan, Wenqiang Xie, Rui Huang, Na Sun, Shuyi Wei, Xuemei Zhou, Yinghua Chen, Yanye Liu, Zhi Li, Qifa Liu, Yongrong Lai

Blood (2023) 142 (Supplement 1): 5252.

https://doi.org/10.1182/blood-2023-180056

Published: 2023

Journal Articles

Letermovir Prophylaxis for Cytomegalovirus Reactivation in β Thalassemia Major Children after Hematopoietic Cell Transplantation

Lingling Shi, Rongrong Liu, Zhongming Zhang, Cuifeng Huang, Lianjin Liu, Yibin Yao, Zhenbin Wei, Shuyi Wei, Zhaoping Gan, Na Sun, Beicai Liu, Rui Huang, Xuemei Zhou, Yinghua Chen, Qifa Liu, Yongrong Lai

Blood (2023) 142 (Supplement 1): 7053.

https://doi.org/10.1182/blood-2023-189043

Published: 2023

Journal Articles

Basiliximab in the Prevention of aGVHD for Unrelated Donor Hematopoietic Stem Cell Transplantation in Patients with Thalassemia Major: A Prospective, Multicenter, Open-Label, Randomized Controlled Study

Rongrong Liu, Meiqing Wu, Qiaochuan Li, Lianjin Liu, Chunjie Qin, Hong Chen, Lingling Shi, Gaohui Yang, Zeyan Shi, Zhongqing Li, Zhenbin Wei, Beicai Liu, Jing Fan, Yinghua Chen, Xuemei Zhou, Zhongming Zhang, Yongrong Lai, Qifa Liu

Blood (2022) 140 (Supplement 1): 1383–1384.

https://doi.org/10.1182/blood-2022-166003

Published: 2022

Journal Articles

Preliminary Result of the Safety and Efficacy of Autologous HBG1/2 Promoter-Modified CD34+ Hematopoietic Stem and Progenitor Cells (RM-001) in Transfusion-Dependent Βeta-Thalassemia

Rongrong Liu, Hui Xu, Junbin Liang, Wenqiang Xie, Gaohui Yang, Lei Shi, Lingling Shi, Jianpei Fang, Chunfu Li, Zeyan Shi, Xuemei Zhou, Junjiu Huang, Yongrong Lai

Blood (2022) 140 (Supplement 1): 4915–4916.

https://doi.org/10.1182/blood-2022-169151

Published: 2022

Journal Articles

Idarubicin Intensified Bucy Regimen in Allogeneic Peripheral Blood Stem Cell Transplantation for High-Risk Acute Myeloid Leukemia: A Multicenter, Randomized Study (NCT 01766375)

Qiaochuan Li, Meiqing Wu, Zhongming Zhang, Lianjin Liu, Lingling Shi, Qifa Liu, Yongrong Lai

Blood (2017) 130 (Supplement 1): 597.

https://doi.org/10.1182/blood.V130.Suppl_1.597.597

Published: 2017

NARROW

A Multi-Center Clinical Trial of Allogeneic Hematopoietic Stem Cell Transplants in Transfusion Dependent Thalassemia

Rapid, Efficient and Durable Fetal Hemoglobin Production Following CS-101 Treatment in Transfusion-Dependent β-Thalassemia Participants: An Autologous, Ex Vivo Edited CD34+ Stem Cell Product Using the Innovative Transformer Base Editor (tBE)

Addition of Daclizumab to Standard Graft-Versus-Host Disease Prophylaxis in Patients with Thalassemia Major Undergoing Transplantation from Alternative Donor Hematopoietic Stem-Cell Transplantation: A Single-Center Retrospective Analysis from China

Pulmonary Dysfunction in Patients with Transfusion-Dependent Thalassemia

Using T-Lymphocyte Subsets at Engraftment to Predict the Risk of Acute Graft Versus Host Disease in Patients with Thalassemia Major：Development of a New Predictive Nomogram

The Optimal Dose of Anti-Thymocyte Globulin in Beta-Thalassemia Major Following Matched Sibling Donor Hematopoietic Stem Cell Transplantation: A Single-Center, Open-Label, Randomized, Controlled Clinical Study

Safety and Efficacy of RM-001 (Autologous HBG1/2 Promoter-modified CD34+ Hematopoietic Stem and Progenitor Cells) in Patients with Transfusion-Dependent β-Thalassemia

Addition of Daclizumab to Standard Graft-Versus-Host Disease Prophylaxis in Patients with Thalassemia Major Undergoing Transplantation from Related Haploidentical Donor and Unrelated Donor Hematopoietic Stem-Cell Transplantation: A Single-Center Retrospective Analysis from China

Letermovir Prophylaxis for Cytomegalovirus Reactivation in β Thalassemia Major Children after Hematopoietic Cell Transplantation

Basiliximab in the Prevention of aGVHD for Unrelated Donor Hematopoietic Stem Cell Transplantation in Patients with Thalassemia Major: A Prospective, Multicenter, Open-Label, Randomized Controlled Study

Preliminary Result of the Safety and Efficacy of Autologous HBG1/2 Promoter-Modified CD34+ Hematopoietic Stem and Progenitor Cells (RM-001) in Transfusion-Dependent Βeta-Thalassemia

Idarubicin Intensified Bucy Regimen in Allogeneic Peripheral Blood Stem Cell Transplantation for High-Risk Acute Myeloid Leukemia: A Multicenter, Randomized Study (NCT 01766375)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only